ESC Guidelines on the diagnosis and management of acute pulmonary embolism

By A. Torbicki, G. Agnelli, N. Danchin, M. Huisman, M. Humbert, N. Kucher, I. Lang, M. Lankeit, J. Lekakis, C. Maack and 11 more. 2014

1,965 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study (2016, methodology): “For venous thromboembolism, we defined recurrent events as admissions occurring >3 months after the initial diagnosis as guidelines recommend at least 3 months of anticoagulant therapy following venous thromboembolism.(10) All ICD codes used in the study are provided in online supplementary table S1”
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019, background): “UFH may be administered during continuous infusion of alteplase, but should be discontinued during infusion of streptokinase or urokinase.(65) Reteplase,(286) desmoteplase,(287) or tenecteplase(179,278,279) have also been investigated; at present, none of these agents are approved for use in acute P”
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. (2012, background): “There is new moderate quality evidence that CDT can reduce PTS of the leg90 (Table 14, e-Table 15) and that systemic thrombolysis increases bleeding in patients with acute PE,143,147 and low-quality evidence that CDT can accelerate breakdown of acute PE.154 This evidence has indirect bearing on thro”